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Background: Despite record rates of childhood obesity, effective evidence-based treatments remain elusive. While
prolonged tertiary specialist clinical input has some individual impact, these services are only available to very few
children. Effective treatments that are easily accessible for all overweight and obese children in the community are
urgently required. General practitioners are logical care providers for obese children but high-quality trials indicate
that, even with substantial training and support, general practitioner care alone will not suffice to improve body
mass index (BMI) trajectories. HopSCOTCH (the Shared Care Obesity Trial in Children) will determine whether a
shared-care model, in which paediatric obesity specialists co-manage obesity with general practitioners, can
improve adiposity in obese children.
Design: Randomised controlled trial nested within a cross-sectional BMI survey conducted across 22 general
practices in Melbourne, Australia.
Participants: Children aged 3–10 years identified as obese by Centers for Disease Control criteria at their family
practice, and randomised to either a shared-care intervention or usual care.
Intervention: A single multidisciplinary obesity clinic appointment at Melbourne’s Royal Children’s Hospital,
followed by regular appointments with the child’s general practitioner over a 12 month period. To support both
specialist and general practice consultations, web-based shared-care software was developed to record assessment,
set goals and actions, provide information to caregivers, facilitate communication between the two professional
groups, and jointly track progress.
Outcomes: Primary - change in BMI z-score. Secondary - change in percentage fat and waist circumference; health
status, body satisfaction and global self-worth.
Discussion: This will be the first efficacy trial of a general-practitioner based, shared-care model of childhood
obesity management. If effective, it could greatly improve access to care for obese children.
Trial Registration: Australian New Zealand Clinical Trials Registry ACTRN12608000055303* Correspondence: melissa.wake@rch.org.au
1Royal Children’s Hospital, Parkville, VIC, Australia
2Murdoch Childrens Research Institute, Parkville, Australia
Full list of author information is available at the end of the article
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Despite recent indications that the upward trend in child-
hood obesity is plateauing, its prevalence remains at histor-
ically high levels [1]. Although childhood obesity affects
around 6% (approximately 200,000) of all Australian chil-
dren, very few of them receive treatment from their general
practitioner or paediatrician [2,3]. Effective evidence-based
treatments remain scarce and are generally only available
to small proportions of seriously obese children through
tertiary care settings. Whilst prevention must ultimately
be the main goal, there are already a large number of
obese children who urgently require effective treatment
if the consequences for their adult health – such as heart
disease and diabetes, psychological morbidity, and massive
excess health care costs – are to be avoided.
So far, the only healthcare setting that is consistently
documented to reproducibly improve the body composition
and health of obese children is the specialist obesity clinic,
generally involving lifestyle advice, motivation and feedback
provided by a multidisciplinary team over a year or more.
Mean reductions in body mass index (BMI) z-score
sustained to at least 12 months are typically around 0.3
[4]; approximately 85% of children typically achieve at
least some overall reduction in BMI z-score although only
around 30% achieve the reduction of ≥0.5 [4,5] that
equates to definite reductions in fat mass [6] and quantifi-
able improvements in risk factors for heart disease and
diabetes [4,7]. Unfortunately, although intervention
appears more successful for younger children, the case-
load of specialist obesity clinics is often typically skewed
towards adolescents with significant psychological, social
and family dysfunction for whom treatment is less effect-
ive [4]. Furthermore, such clinics are inaccessible to
almost all children. By our estimation the nine obesity
clinics in children’s hospitals around Australia could see,
at most, around 0.05% of affected Australian children each
year, and it seems likely that other countries would have
similar situations.
Therefore, as the only universally-accessible healthcare
service available throughout childhood, general practice
might seem the obvious healthcare setting to support the
improvement, achievement and maintenance of healthy
weight in children who are already overweight or obese.
However, trials of obesity approaches in which treatment is
initiated and carried out solely by general practitioners, with
or without allied health services, have been extraordinarily
disappointing to date both for adults [8] and children
[9–12]. A new approach is therefore needed to augment the
treatment of childhood obesity in primary care.
Nonetheless, there remain good reasons for optimism
when considering general practice as a mode for the suc-
cessful management of paediatric obesity. Firstly, this is
where the majority of overweight/obese children present. In
a study of 3000 Victorian primary school children, parentsreported that 55% of overweight children had attended a GP
once or twice in the preceding six months, and 22% three
or more times [13]. In two subsequent randomised con-
trolled trials, we have also shown that: (1) general practi-
tioners can and do take up training to offer a series of
structured consultations using strategies for family lifestyle
change, (2) that they are able to systematically identify chil-
dren in the overweight and obese categories, (3) that fam-
ilies are willing for their children to be screened for BMI
and not only engage, but persist, with their general practi-
tioner, and (4) that this approach does not appear to be
harmful for overweight or mildly obese children [10,14].
GPs are very clear that the management of childhood obes-
ity falls within their role [15] and with training they can feel
comfort and competent in this area [16].
The literature on shared-care approaches incorporating
primary and specialist partnerships is relatively limited but
encouraging in achieving similar [17,18] or better [19] dis-
ease outcomes with important ancillary outcomes such as
increased satisfaction [20] and reduced waiting times [21].
For instance, an adult rheumatoid arthritis trial demon-
strated higher quality-adjusted life-years for the shared-care
than the aggressive arm [18], while a shared-care interven-
tion for patients newly diagnosed with cancer increased gen-
eral practitioner contact and positively influenced patients’
attitudes toward the healthcare system [17]; in neither trial
was the disease outcome poorer in the shared-care arm.
However, few shared-care trials have focused on children,
and none on childhood obesity.
Given the potential benefits of health information tech-
nology to general practice [22], the Australian government
has prioritised its use and value [23] with the result that, by
2005, 80% had broadband access and nearly 90% used a
computer for clinical purposes [24], and is most likely close
to 100% as of 2011. Some health information technology
features are already nearly universally (eg prescribing) or fre-
quently (eg accessing patient educational material) used, but
far fewer general practitioners (<20%) are accessing compu-
terised clinical information or using online decision support
during consultations [24]. It is clear that e-health has both
promise and limitations [25] and that the potential will not
be actualised without carefully designing e-health initiatives
into the primary care process. Health information technol-
ogy could present an excellent mechanism to enhance
shared-care models.
The HopSCOTCH (Shared Care Obesity Trial in Chil-
dren) randomised trial is the first to our knowledge to study
the efficacy of a general-practitioner based, shared-care
model in reducing obesity in children – a population rela-
tively underserved by evidence-based approaches [26]. The
intervention needs to be developed in such a way that it
could be widely implemented with consistency and sustain-
ability, but with relatively little training. Underpinning this
would be a very practical software platform that would
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also enhancing primary-specialty care partnerships. The
software would also support continuing practice improve-
ment activities and the individual practitioner feedback that
has proved useful in many fields [27]. Essentially, we hope
to replicate the effectiveness of the specialty obesity clinic in
the general practice setting, with attention to feasibility, sus-
tainability and a wider and more systematic availability.
Aims and hypothesises
The aim of the HopSCOTCH trial is to develop, imple-
ment and trial an innovative shared-care approach to
manage childhood obesity. We will compare outcomes
for 3–10 year old obese children randomised to a
shared-care model (general practitioners working with
paediatric obesity specialist, consisting of a paediatrician
and dietician - ‘intervention’ group) with outcomes for
those receiving usual patient-driven primary care (‘con-
trol’ group).
We hypothesise that:
1. Compared to the control group, the intervention
children will demonstrate better outcomes at
15 months in terms of lower:
i) Relative BMI, measured as a z-score (primary
outcome)
ii) Percentage body fat
iii)Waist circumference
2. Compared to the control group, the intervention
children will not show evidence of harm (ie poorer
health status, body satisfaction, or global self-worth)
at 15 months.
3. The intervention will be acceptable and feasible to
(i) parents, (ii) general practitioners, (iii) general
practice staff, and (iv) the obesity specialists.
Methods and Design
Approval and registration
The project is funded by the National Health and Med-
ical Research Council of Australia (Project Grant
491212). It has been approved by the Royal Children’s
Hospital Melbourne Human Ethics Committee (28017)
and The University of Melbourne Human Research Eth-
ics Committee (0827435).
Design
HopSCOTCH is a randomised controlled trial of a
shared-care intervention versus usual care in obese chil-
dren (see Figure 1). The trial commenced in April 2008
and will run until December 2011. This period encom-
passes participant recruitment, baseline data collection,
intervention delivery, follow up data collection (15 months
post-recruitment, equating to approximately 12 months
post-intervention) and data analysis.Participants
Participants are (1) 120 children aged 3–10 years, identi-
fied as obese according to the United States Centres for
Disease Control (CDC) charts (≥95th age- and sex-specific
percentile) [28]; and (2) their parents. Children were iden-
tified through participating general practitioners (GPs).
GP recruitment and training
To recruit GPs, HopSCOTCH was widely advertised
through the Royal Australian College of General Practi-
tioners and the Victorian general practice research
network ‘VicReN’ e-bulletins/newsletters. Personalised
invitations were also sent to GPs who previously partici-
pated in the LEAP 1 and LEAP 2 trials [10,29]. Of the
70 GPs who initially expressed interest, 35 GPs across
22 practices decided to take part.
GPs attended a 2½ hour group training session for in-
struction in the “stages of change” model [30] and training
in brief, solution-focused family therapy [31]. GPs were
shown role model scenarios of GPs using solution-focused
therapy in consultations for healthy family lifestyle and
given the opportunity to mimic these skills themselves with
colleagues in role play scenarios designed by the research
team. GPs also completed readings on current obesity man-
agement, followed by a brief online quiz to test their know-
ledge and training in measuring protocols. Those delivering
the intervention received one-on-one training in how to
use the specially designed shared-care software. GPs were
provided with the following remuneration for their time
and for bulk-billing all shared-care patients: $220 for
attending the training sessions; $25 per child recruited from
their practice; and $75 for GPs that saw shared-care
patients five times and an additional $75 if they saw them
eight or more times.
Recruitment of children
To recruit children, HopSCOTCH was publicised in par-
ticipating practices through posters, brochures and prac-
tice staff. Trained general practice staff opportunistically
offered to weigh and measure children using calibrated
digital scales and rigid stadiometers supplied by the re-
search team. Eleven practices also sent letters to all of
their in-age children inviting them to attend a dedicated
weigh and measure session run by the research team or
practice staff at the practice. With parent assent, their
contact details and child anthropometry data were then
mailed or faxed to the research team. Upon receipt, the
research team calculated each child’s BMI and BMI per-
centile. Provided parents had left contact details, ineli-
gible children’s families were sent a letter informing
them of their ineligibility, while eligible families were tel-
ephoned to propose participation in the trial. Interested
eligible families were mailed a parent information sheet,
consent form and parent baseline questionnaire. Upon
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Children screened for eligibility by measuring height and weight at participating general 
practices across Melbourne. Researchers contact eligible families to invite the family into
the trial. Interested families mailed a baseline parent questionnaire and consent form.
Participating GPs return a Memorandum of Understanding and complete a baseline
questionnaire. GPs undergo training to deliver intervention.
Children are enrolled into the trial and randomised upon return of the baseline parent 
questionnaire and consent form. 
Intervention arm children and parent/s attend a tertiary weight management clinic 
appointment with obesity specialists. 
Intervention arm children and parent/s attend a 15 to 30 minute GP appointment to
receive weight management counselling, goal-setting, and tracking of progress. 
The obesity specialists perform a formal review of each intervention child’s progress
using information in the shared care software and received from the child’s participating 
GP. The obesity specialists send a letter of guidance to the GP about each patient. 
Home visit conducted by a researcher blinded to allocation status to collect outcome
data.
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Figure 1 Graphical depiction of components of the HopSCOTCH trial.
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baseline questionnaire, families were enrolled in the trial.
Inclusion and exclusion criteria
Inclusion criteria
Eligible families included children who met both the fol-
lowing requirements:
1) BMI ≥95th for age- and sex-specific percentile
according to the CDC charts, placing them in the
obese range; and
2) aged between 3 and 10 years (i.e. up to but not
including their 11th birthday).
Exclusion criteria
Children were excluded if they met any of the following
criteria:
1) receiving ongoing weight management in a
secondary or tertiary care program;
2) a known endocrine or genetic cause for their
obesity;
3) a major disability or health condition judged by
parents and/or researchers to preclude meaningful
participation;
4) their family did not speak sufficient English to
complete questionnaires and participate in the trial.
Randomisation and blinding
Randomisation occurred via a concealed, computerised
random number sequence stratified by general practi-
tioner and pre-generated by the Clinical Epidemiology
and Biostatistics Unit at the Royal Children’s Hospital.
Once enrolled (i.e. on receipt of written informed consent
and baseline questionnaire) a research assistant, who was
not otherwise involved with the trial, randomised children
to either the shared-care or usual-care arm. All families
were advised of their child’s allocation by a mailed letter.
All outcome measures were collected by researchers
blinded to the child’s allocation status.
Intervention arm
Shared-care software
A web-based shared-care software was designed with the
goals of 1) allowing the obesity specialists and GPs to col-
laborate and communicate closely in the care of their
patients, 2) providing a structured yet efficient approach
to weight management care, and 3) providing a mechan-
ism that allows both GPs and specialists to record and
track patient progress simultaneously. The software’s
weight management care plan consists of five steps: 1)
recording anthropometry, 2) reviewing BMI change using
an online chart to plot and track BMI visually over time
against percentile charts, 3) assessing and tracking pro-
gress and motivation, 4) reviewing care plan (i.e. issues
and goals), and 5) providing educational resources.The HopSCOTCH software, developed in collaboration
with Pen Computer Systems Pty Ltd (PCS), was designed to
support specialist and GP management of children with
obesity and to facilitate communication of information be-
tween the health care providers involved. Specifically, the
HopSCOTCH system provides notification and communi-
cation between providers of care, access to patient informa-
tion for care team members via the shared web-based
HopSCOTCH record, obesity assessment and management
tools, and help in developing a detailed management plan
and history. Printouts of plans, educational resources and
patient summaries can also be obtained. HopSCOTCH is
launched from a desktop application, the PrimaryCare Side-
barW, a proprietary product of PCS. The PrimaryCare Side-
barW sits on the right of the screen (by default) and contains
a series of panels, each with links to a range of primary care
software tools. The panels allow the tools to be grouped into
logical areas of health care. The HopSCOTCH system is
accessed via the PCS Linked CareTM panel.
Obesity specialist consultation
The shared-care intervention involved each family (at a
minimum the index child and one parent/guardian)
attending a single one-hour session at Melbourne’s Royal
Children’s Hospital, where they saw the obesity specialist
team comprising a paediatrician and a paediatric diet-
ician who specialise in childhood obesity and weight
management. Prior to the appointment, researchers
extracted clinically-relevant information about the child
and family from the baseline questionnaire, including
family history, medical history, daily diet, physical activ-
ity and sedentary activities, and scored multi-item scales
(see Additional file 1). These data were entered into a
summary, with abnormal values flagged, in order to both
save time on history-taking and to provide additional in-
formation that would not normally be available during a
single first clinical consultation (see completed example
Additional file 1). This allowed the team to devote more
consultation time exploring lifestyle modification, rather
than primarily information gathering.
At the appointment, a researcher first measured the
child’s height, weight and percentage of truncal fat. The
paediatrician then interviewed the child and family, tak-
ing a clinical history and examining the child using a
standard protocol to identify possible causes and co-
morbidities of obesity. The dietician then undertook a
detailed dietary history and outlined general principles
of healthy eating, offering targeted advice based on the
child and family’s eating patterns. Physical and sedentary
activities were assessed and, together, the paediatrician
and dietician then discussed the lifestyle changes
required that would most likely assist in successful
weight management for the child. This advice focussed
on family change and support, in accordance with
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parents are involved [32], and is consistent with current
recommendations that, for most obese children, BMI re-
duction is best achieved by maintaining, rather than los-
ing, weight as the child grows [33]. Details of the
specialist consultation, including the clinical summary
and pathology results (if applicable) and an initial care
plan, were then entered into the shared-care software.
If clinically indicated, parents/guardians were asked to
bring their child to the Pathology Department at the
Royal Children’s Hospital within the next 2–3 weeks for
standard metabolic tests such as a check of thyroid func-
tion. These results were also entered into the shared-
care software so the GP could access them.
GP consultations
After the specialist appointment, a follow-up appoint-
ment with the child’s GP was scheduled by the research
team. Both the specialist and research team encouraged
families to see their GP for regular (i.e. every 4–8 weeks)
weight management consultations for a year following
the specialist consultation. Information from the obesity
specialists was available to all GPs via the shared-care
software, including the family’s customised care plan.
The weight management GP consultations were
designed to: 1) review lifestyle and BMI progress; 2) iden-
tify and solve problems where possible; and 3) set new
goals using brief solution-focused techniques. The obesity
specialists were available to the GP on an ‘as-needed’ basis
throughout the trial. At the 6-month point, the obesity
specialists formally reviewed each family’s progress using
the synchronised software, with a focus on solutions and
guidance for GPs. Each family’s review generated a one-
page letter that was sent to the treating GP.
Control arm
Participants in the usual-care (control) arm were not
offered an obesity clinic appointment or identified as
being in the trial to their GP. Parents were informed that
they were free to seek assistance with their GP or with
any other service. Should they present to their GP, the
GP would be able to implement their usual clinical care
and utilise skills gained in the training process, but they
were not able to access the shared-care software to track
progress, educational resources or access support from
the obesity specialists regarding these patients.
Measures and training
Table 1 summarises all outcome measures for the trial,
with the primary outcome being BMI expressed as kg/m2
[33]. All outcomes will be measured at 15 months post-
randomisation, equating to approximately 12 months after
the clinical consultation for the intervention children.All researchers involved in baseline and outcome mea-
surements were trained by researchers experienced in
conducting similar measurements in the community
from other research trials and longitudinal studies in
childhood obesity. Researchers were trained at a single
one-hour session where each measurement was demon-
strated and repeatedly practised to ensure accuracy,
competency, and reliability.
Process evaluation
Process evaluation will be completed by parents and
GPs. The items will document extent to which interven-
tions were implemented, acceptability, barriers to at-
tendance, and perceived harms and benefits. Parents will
report other assistance received (source, type, intensity)
for their children’s weight status.
Economic evaluation
If the intervention is effective, we will proceed to a full
economic evaluation. This will comprise !analysis con-
ducted from both societal and health care perspectives
[34], as interventions cost-effective from a health care
perspective can add substantially to family costs [35].
This will compare any incremental costs of the interven-
tion (over the control group) to all incremental out-
comes detailed above. Resources used in intervention
design, development and delivery have been prospectively
documented via research team records, the trial database,
hospital and general practice records, and parental report
and valued using existing unit cost estimates. Uncertainty
in the cost and outcome data and sensitivity of results to
the evaluation methods chosen will be tested through ex-
tensive sensitivity analyses.
Sample size
The target sample size was calculated to detect a mean
difference of 0.3 BMI z-score units at 15 months (com-
parable to published mean changes seen from specialist
obesity clinics[4]) between arms with 80% power at 5%
(2 sided) level of significance. Allowing for 10% loss to
follow-up, we aimed to recruit 172 children.
Data Analysis
Analyses will be by ‘intention to treat’ at the level of the
individual child. Linear regression will be used to com-
pare quantitative outcomes between the trial groups
adjusting for confounders and baseline measures of the
outcomes where these are available, using an analysis of
covariance approach. Logistic regression will be used to
compare dichotomous outcomes.
Confounders selected a priori for multivariable models
will include child sex, age at randomisation, and family
socioeconomic status, which will be assigned according
to postal code of residence using the Index of Relative
Table 1 Primary and secondary outcome measures for the HopSCOTCH trial
Construct Time Point Measure Additional information
Baseline Outcome
Primary Outcome
Body Mass Index
(kg/m2)
• • Portable rigid stadiometer
(model IP0955, Invicta,
Leicester, UK);
measured
Calibrated digital scale
(model TITHD646,
Tanita, Toyko, Japan);
measured
Height is measured twice and the average used; if the values
differ by >0.5 cm a third measurement is taken and the average
of the two closest values used.Weight, while wearing light
clothing, is measured once at baseline, and measured twice at
outcome. Average weight used at outcome; if the values differ
by ≥0.2 kg a third measure was taken and average of the two
closest values used.
BMI is calculated as weight (kg)/(height (m)2). BMI z-score
is calculated according to the US Centers for Disease Control
(CDC) reference values [28], using the Stata ‘zanthro’ function.
Secondary Outcomes
Waist
circumference
• Lufkin Executive Steel
Tape (W606PM);
measured
Average of two waist measurements; if they differ by ≥1 cm,
a third measurement is taken and the mean of the two
closest used.
Body fat (%) • Tanita Digital Body
Composition Monitor
(BC-351)[37]; measured
Average of two body percentage fat measurements.
Blood pressure/
heart rate
• Welch Allyn ProBP3400;
measured
Three blood pressure/heart rate readings are taken at
least two minutes apart on the right arm with the
child sitting; the average of the two closest readings is used.
Nutrition • 4 day food diary;
parent report
Parents report child’s consumption of each of 17 food
and drink items (0, 1, 2, >2 times) for two weekdays and
two weekend days. Dichotomous (“yes” v “no”) variables are
derived for five “healthy behaviours” (high fruit, vegetables,
and water; low fatty/sugary foods and non-diet sweet
drinks) for each day. The number of healthy behaviours
per day are summed to give a score between 0 and 5
(higher score indicating more healthy behaviour).
Physical activity • Actical Accelerometer
(Mini Mitter); measured
Worn for 7 full days; ≥5 valid days required. Valid days
have ≥10 hours of non-missing data between 6 am-11 pm.
Missing data are segments with ≥20 minutes of consecutive
“0” counts, or counts >0 that are constant for ≥10 minutes.
Outcomes across all valid days: mean activity counts/min,
and % time spent in moderate to vigorous physical activity.
Health status • • Paediatric quality of life
inventory (PedsQL 4.0);
self report and parent-proxy
versions [38]
Parent-completed 23-item scale that yields total,
physical summary, and psychosocial summary
scores, each with a possible range of 0–100
(100 = best possible health); quantitative variable.
Body dissatisfaction • Body figure perception
questionnaire; self report [39]
Child picture scale of 1–7 (1 = underweight, 7 = obese)
from which child picks perceived and ideal selves.
“Perceived” minus “Ideal” self yields a discrepancy
index, with positive and negatives scores representing
desires to be thinner and fatter, respectively.
Physical appearance and
self worth
• Modified from
Harter’sperceived
competencescale; self report
Six pairs of statements with binary response format;
children choose the statement from each pair that
is closest to their competence. Each of the 6
responses is then coded as being either “positive/better
perception” or “negative/worse perception”.
The 6 responses are analysed as a single outcome.
Behaviour • Strengths and difficulties
questionnaire
[40]; self report
Parent-completed 25-item scale that yields
scores for conduct problems, emotional symptoms,
hyperactivity, peer relationships and pro-social behaviour.
Parent Readiness to change • • Parent’s readiness to change
child’s
weight[41]; self report
3 items, each with a possible 5 responses
(strongly agree – strongly disagree).
Parent BMI • Weight (kg)/(height (m)2);
measured and self report
Baseline values reported for self and partner by responding
parent. Values at 12 months measured for the parent(s) present
with the child and reported; measured data used preferentially.
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the Australian Bureau of Statistics census-based Socio-
Economic Indexes for Areas (SEIFA) [36].
Discussion
Without more effective evidence-based treatments to
reduce the childhood obesity, we are heading into
uncharted territory. Large numbers of obese children
are now reaching adulthood, with yet-to-be-quantified
impacts on obesity-related comorbidities such as dia-
betes, poor mental health, hypertension, heart disease
and cancers - which would in turn lead to increased
health services costs.
If effective, shared-care models for childhood obesity
have the potential to offer obese children effective treat-
ment that is easily accessible. Benefits would include
increased general practitioner identification of childhood
obesity; a shift in focus towards younger obese children
(for whom treatment is more effective and secondary
prevention of morbidity is still possible); and a model for
sustainable, supported partnerships between primary
and specialist care with substantially better results than
the disappointing stand-alone primary care trials to date.
Additional file
Additional file 1: HopSCOTCH Pre-Specialist Summary.
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